Reply to M. Romero et al

Affiliations

¹ Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Comment

Elaine S Jaffe et al. J Clin Oncol. 2020.

. 2020 Aug 20;38(24):2819-2820.

doi: 10.1200/JCO.20.00931. Epub 2020 Jun 17.

¹ Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

No abstract available

Comment on

Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Jaffe ES, Ashar BS, Clemens MW, Feldman AL, Gaulard P, Miranda RN, Sohani AR, Stenzel T, Yoon SW. Jaffe ES, et al. J Clin Oncol. 2020 Apr 1;38(10):1102-1111. doi: 10.1200/JCO.19.02778. Epub 2020 Feb 11. J Clin Oncol. 2020. PMID: 32045544 Free PMC article.
Should Flow Cytometry Be Considered a First Line of Study in the Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma?
Romero M, Melo A, Bedoya N, de la Hoz J, Mejía-Arango M, Galvis K, Hernandez L, Cuellar G, Martin L, Quijano S, Saavedra C. Romero M, et al. J Clin Oncol. 2020 Aug 20;38(24):2816-2819. doi: 10.1200/JCO.20.00712. Epub 2020 Jun 17. J Clin Oncol. 2020. PMID: 32552470 No abstract available.

1. Romero M, Melo A, Bedoya N, et al. Should flow cytometry be considered a first line of study in the diagnosis of breast implant–associated anaplastic large-cell lymphoma? J Clin Oncol 38:2816-28192020 - PubMed
1. Jaffe ES, Binita AS, Clemens MW, et al. Best practices guideline for the pathologic diagnosis of breast implant–associated anaplastic large-cell lymphoma. J Clin Oncol. 2020;38:1102–1111. - PMC - PubMed
1. Farkash EA, Ferry JA, Harris NL, et al. Rare lymphoid malignancies of the breast: A report of two cases illustrating potential diagnostic pitfalls. J Hematop. 2009;2:237–244. - PMC - PubMed
1. Mescam L, Camus V, Schiano JM, et al. EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant–related lymphomas Blooddoi:10.1182/blood.2019003408 [epub ahead of print on February 28, 2020] - DOI - PubMed
1. Boyer DF, McKelvie PA, de Leval L, et al. Fibrin-associated EBV-positive large B-cell lymphoma: An indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation. Am J Surg Pathol. 2017;41:299–312. - PubMed